News | November 03, 2023
Dabur India posts Q2 FY24 consolidated PAT at Rs. 515.05 Cr
The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023
The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023
Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023
Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
